Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
PANTOPRAZOL NATRIUM 1,5-WATER 22,6 mg/stuk SAMENSTELLING overeenkomend met ; PANTOPRAZOL 20 mg/stuk
Sandoz B.V. Veluwezoom 22 1327 AH ALMERE
A02BC02
PANTOPRAZOL NATRIUM 1,5-WATER 22,6 mg/stuk SAMENSTELLING overeenkomend met ; PANTOPRAZOL 20 mg/stuk
Maagsapresistente tablet
CALCIUMSTEARAAT (E 470A) ; CELLULOSE, MICROKRISTALLIJN (E 460) ; CHINOLINEGEEL ALUMINIUMLAK (E 104) ; COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1) ; CROSPOVIDON (E 1202) ; HYPROLOSE (E 463) ; HYPROMELLOSE (E 464) ; IJZEROXIDE GEEL (E 172) ; MACROGOL 400 ; NATRIUMCARBONAAT 0-WATER (E 500 (I)) ; NATRIUMLAURILSULFAAT (E 487) ; POLYSORBAAT 80 (E 433) ; PONCEAU 4R ALUMINIUMLAK (E 124) ; SILICIUMDIOXIDE (E 551) ; TITAANDIOXIDE (E 171) ; TRIETHYLCITRAAT (E 1505),
Oraal gebruik
Pantoprazole
Hulpstoffen: CALCIUMSTEARAAT (E 470A); CELLULOSE, MICROKRISTALLIJN (E 460); CHINOLINEGEEL ALUMINIUMLAK (E 104); COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1); CROSPOVIDON (E 1202); HYPROLOSE (E 463); HYPROMELLOSE (E 464); IJZEROXIDE GEEL (E 172); IJZEROXIDE ROOD (E 172); IJZEROXIDE ZWART (E 172); MACROGOL 400; MACROGOL 600; NATRIUMCARBONAAT 0-WATER (E 500 (I)); NATRIUMLAURILSULFAAT (E 487); POLYSORBAAT 80 (E 433); PONCEAU 4R ALUMINIUMLAK (E 124); POVIDON (E 1201); SCHELLAK (E 904); SILICIUMDIOXIDE (E 551); TITAANDIOXIDE (E 171); TRIETHYLCITRAAT (E 1505);
2011-02-01
Sandoz B.V. Page 1/7 Previfect 20 mg, maagsapresistente tabletten RVG 105877 1313-V17 1.3.1.3 Package Leaflet November 2023 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT PREVIFECT ® 20 MG, MAAGSAPRESISTENTE TABLETTEN pantoprazole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET 1. What [Nationally completed name] is and what it is used for 2. What you need to know before you take [Nationally completed name] 3. How to take [Nationally completed name] 4. Possible side effects 5. How to store [Nationally completed name] 6. Contents of the pack and other information 1. WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR [Nationally completed name] contains the active substance pantoprazole, which blocks the ‘pump’ that produces stomach acid. Hence it reduces the amount of acid in your stomach. [Nationally completed name] is used for the short-term treatment of reflux symptoms (for example heartburn, acid regurg Lees het volledige document
Sandoz B.V. Page 1/11 Previfect 20 mg, maagsapresistente tabletten RVG 105877 1311-V13 1.3.1.1 Summary of Product Characteristics November 2023 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Previfect 20 mg, maagsapresistente tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each gastro-resistant tablet contains 20 mg pantoprazole (as sodium sesquihydrate). Excipient with known effect Each gastro-resistant tablet contains 1 microgram of azo colouring agent Ponceau 4R aluminium lake (E 124). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Gastro-resistant tablet Yellow, oval coated tablet, approx.. 8.9 x 4.6 mm. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS [Nationally completed name] is indicated for short-term treatment of reflux symptoms (e. g. heartburn, acid regurgitation) in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The recommended dose is 20 mg pantoprazole (one tablet) per day. It might be necessary to take the tablets for 2-3 consecutive days to achieve improvement of symptoms. Once complete relief of symptoms has occurred, treatment should be discontinued. The treatment should not exceed 4 weeks without consulting a doctor. If no symptom relief is obtained within 2 weeks of continuous treatment, the patient should be instructed to consult a doctor. Special populations _ _ No dose adjustment is necessary in elderly patients or in those with impaired renal or liver function. _Paediatric population _ [Nationally completed name] is not recommended for use in children and adolescents below 18 years of age due to insufficient data on safety and efficacy. Sandoz B.V. Page 2/11 Previfect 20 mg, maagsapresistente tabletten RVG 105877 1311-V13 1.3.1.1 Summary of Product Characteristics November 2023 Method of administration [Nationally completed name] should not be chewed or crushed, and should be swallowed whole with liquid before a meal. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in sec Lees het volledige document